BlossomHill Therapeutics, Inc.(BLSM)
$16.12+1.88 (+13.20%)
BLSM
BlossomHill Therapeutics, Inc. financials statements
$16.12
At close:+1.88 (+13.20%)
Want to see BLSM full AI Analyst Report?
BlossomHill Therapeutics, Inc. (BLSM) Financial Statements
17 Followers
BlossomHill Therapeutics, Inc. Financial Overview
BlossomHill Therapeutics, Inc.'s market cap is currently $452.62M. The company's EPS TTM is $-9.47; its P/E ratio is -1.70; BlossomHill Therapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 |
| Operating Income | $ -64.02M | $ -36.40M |
| EBITDA | $ -63.58M | $ -36.05M |
| Net Income | $ -60.55M | $ -30.70M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 136.68M | $ 100.15M |
| Total Assets | $ 162.97M | $ 106.78M |
| Total Debt | $ 22.40M | $ 525.00K |
| Net Debt | $ -114.28M | $ -99.62M |
| Total Liabilities | $ 294.70M | $ 179.66M |
| Stockholders' Equity | $ -131.73M | $ -72.88M |
| Cash Flow | ||
| Free Cash Flow | $ -47.99M | $ -31.51M |
| Operating Cash Flow | $ -46.92M | $ -31.42M |
| Investing Cash Flow | $ -1.07M | $ -92.00K |
| Financing Cash Flow | $ 84.53M | $ 17.56M |
Currency in USD
